Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
In recent years, studies on the use of natural language processing (NLP) approaches to identify dementia have been reported. Most of these studies used picture description tasks or other similar tasks to encourage spontaneous speech, but the use of free conversation without requiring a task might be easier to perform in a clinical setting. Moreover, free conversation is unlikely to induce a learni...
Accurate prediction of clinical scores (of neuropsychological tests) based on noninvasive structural magnetic resonance imaging (MRI) helps understand the pathological stage of dementia (e.g., Alzheimer's disease (AD)) and forecast its progression. Existing machine/deep learning approaches typically preselect dementia-sensitive brain locations for MRI feature extraction and model construction, pot...
OBJECTIVE: While the use of biomarkers for the detection of early and preclinical Alzheimer's Disease has become essential, the need to wait for over ...
BACKGROUND: New research fields to design social robots for older people are emerging. By providing support with communication and social interaction,...
Predicting the various binding sites of a protein from its structure sheds light on its function and paves the way towards design of interaction inhib...
The deep learning models play an essential role in many areas, including medical image analysis. These models extract important features without human...
CNS disorders are indications with a very high unmet medical needs, relatively smaller number of available drugs, and a subpar satisfaction level amon...
INTRODUCTION: Automated computational assessment of neuropsychological tests would enable widespread, cost-effective screening for dementia.
BACKGROUND: Since no effective therapies exist for Alzheimer's disease (AD), prevention has become more critical through lifestyle status changes and ...
Communication interventions have broadened from dialogical meaning-making, assessment approaches, to remote-controlled interactive objects. Yet, inter...
Worldwide, there are nearly 10 million new cases of dementia annually, of which Alzheimer's disease (AD) is the most common. New measures are needed t...
Currently there are no reliable biomarkers for early detection of Alzheimer's disease (AD) at the preclinical stage. This study assessed the pupil lig...
About 40 000 individuals depend on assisted living in long-term care facilities in Norway. Around 80% of these have a cognitive impairment or suffer f...
This study aims to investigate the accuracy of a fine-tuned deep convolutional neural network (CNN) for evaluating responses to the pentagon copying t...
Alzheimer's Disease (AD) is an irreversible neurodegenerative disease that results in a progressive decline in cognitive abilities. Since AD starts se...
INTRODUCTION: To test the utility of the "A/T/N" system in the Chinese population, we study core Alzheimer's disease (AD) biomarkers in a newly establ...
OBJECTIVES: Neuropsychological tests (NPTs) are widely used tools to evaluate cognitive functioning. The interpretation of these tests can be time-con...
The robust use of osmolytes (i.e., polyols and sugars) in the key therapeutic regimens/formulations has questioned their impact beyond the stability o...
PURPOSE: To validate our previously proposed method of quantifying amyloid-beta (Aβ) load using nonspecific (NS) estimates generated with convolutiona...
Predicting the functional sites of a protein from its structure, such as the binding sites of small molecules, other proteins or antibodies, sheds lig...